Résultat de recherche

Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.

Hervé Bachelez

Source :

Pmid / DOI:

Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa.

Asma Smahi, Hervé Bachelez

Source :

Pmid / DOI:

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis.

Hervé Bachelez

Source :

Pmid / DOI:

Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses.

Claire Barbieux, Mathilde Bonnet des Claustres, Olivier Gouin, Florent Leturcq, Christine Bole, Vivien Beziat, Alain Hovnanian

Source :

Pmid / DOI:

Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity.

Source :

Pmid / DOI:

Emerging drugs for the treatment of epidermolysis bullosa.

Matthias Titeux, Mathilde Bonnet des Claustres, Araksya Izmiryan, Hélène Ragot, Alain Hovnanian

Source :

Pmid / DOI:

Drug Repurposing Reveals mTOR Inhibition as a Promising Strategy for Epidermolysis Bullosa Simplex.

Hélène Ragot, Alain Hovnanian

Source :

Pmid / DOI:

Trial of Spesolimab for Generalized Pustular Psoriasis.

Hervé Bachelez

Source :

Pmid / DOI:

SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.

Hervé Bachelez

Source :

Pmid / DOI:

Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa.

Florence Assan , Asma Smahi, Hervé Bachelez

Source :

Pmid / DOI: